Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 650.6% | | | | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 1.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | | | | | |
| Selling, general and administrative | 30.7 | 22.6 | 9.0 | | | 1.9 | |
| Research and development | 36.9 | 41.8 | 31.3 | 51.6 | 88.9 | 10.4 | 6.3 |
| General and administrative | | | | 5.9 | 9.1 | | 1.2 |
| EBIT | -65.8 | -64.2 | -40.3 | -57.5 | -98.0 | -12.4 | -7.5 |
| EBIT margin | -4870.2% | -35672.8% | | | | | |
| Pre-tax income | -64.6 | -63.8 | -40.3 | -57.5 | -96.4 | -12.5 | -8.1 |
| Income taxes | 3.6 | 0.0 | 0.0 | -2.6 | -4.6 | -0.5 | -0.1 |
| Tax rate | | 0.0% | 0.0% | 4.5% | 4.8% | 4.3% | 1.0% |
| Net income | -64.2 | -61.0 | -38.1 | -54.9 | -91.8 | -12.0 | -8.0 |
| Net margin | -4750.5% | -33873.9% | | | | | |
| |
| Diluted EPS | ($1.64) | ($2.03) | ($1.55) | ($2.42) | ($4.40) | ($0.75) | ($0.57) |
| Shares outstanding (diluted) | 39.0 | 30.0 | 24.6 | 22.7 | 20.9 | 16.1 | 13.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|